申请人:Merck & Co., Inc.
公开号:US04125530A1
公开(公告)日:1978-11-14
4(5)-Trifluoromethylimidazoles having optional substituents in the 1 and 2 positions are provided. The novel 4(5)-trifluoromethylimidazoles are prepared by reacting a 1,1-dihalo-3,3,3-trifluoroacetone compound with an appropriate carboxaldehyde and ammonia. The 4(5)-trifluoromethylimidazoles are useful as anti-gout and anti-hyperuricemic agents.
提供了在1和2位置具有可选取代基的4(5)-三氟甲基咪唑。通过将1,1-二卤-3,3,3-三氟乙酮化合物与适当的醛和氨反应制备了新型的4(5)-三氟甲基咪唑。这些4(5)-三氟甲基咪唑可用作抗痛风和抗高尿酸血症药物。